Glucose Monitoring

What We're Reading: Centivo Launches New Plan; Dead Bacteria Provide IBS Relief; Hospitals Using CGM in Patients With COVID-19

April 9th 2020, 6:43pm


Centivo has launched a new health plan solution, aimed at lowering costs for employees; trial results show dead bacteria may be effective in treating IBS; continuous glucose monitoring systems are now being used in hospitalized patients with diabetes and coronavirus disease 2019 (COVID-19).

Women With GDM, Vitamin D Deficiency May Have Higher Risk of Postpartum Glucose Intolerance

April 2nd 2020, 9:42pm


Vitamin D deficiency in women with gestational diabetes mellitus (GDM) is associated with an elevated risk of postpartum glucose intolerance, according to a study published in Endocrinology and Metabolism.

Abbott, DexCom Partner With Insulet to Improve Diabetes Management Technology

February 25th 2020, 9:45pm


Abbott recently announced a partnership with Insulet Corporation to integrate its glucose-sensing technology with an automated insulin delivery system for patients with diabetes. Specifically, Abbott’s FreeStyle Libre system will become compatible with Insulet’s Omnipod Horizon, in an effort to “offer personalized automated insulin delivery and care for people living with diabetes.”

Keeping Glucose in Range, With the Right Tools and Treatment for Management

August 28th 2019, 10:32pm


Coverage from the July 11, 2019, meeting of the Institute for Value-Based Medicine®, an initiative of The American Journal of Managed Care®. The meeting took place in Arlington, Virginia.

Managing Costs in Diabetes Means Intervening Early to Avoid Complications Later, Experts Say

June 30th 2019, 8:21pm


The Los Angeles gathering of the Institute for Value-Based Medicine focused on the need to intervene early in the course of diabetes, so that patients can avoid long-term complications. Over the past decade, cardiovascular outcomes trials for glucose-lowering therapies have revealed unexpected benefits, offering new opportunities for cardiologists.

Using Real-World Evidence to Understand Disparities, Clinical Inertia

June 18th 2019, 1:37am


Merck's Center for Observational and Real-World Evidence has spent several years gathering evidence on clinical inertia and is now working on solutions to overcome it at the point of care.

ADA Issues Time-in-Range Targets for CGM Use

June 14th 2019, 12:24am


The consensus report was presented at the 79th Scientific Sessions of the American Diabetes Association in San Francisco, California.

Real-World Data Show Patients With T2D Reducing A1C With FreeStyle Libre

June 10th 2019, 10:38pm


Patients with type 2 diabetes (T2D) who had been using insulin an average of 8 years and had mean glycated hemoglobin (A1C) levels of 8.9% were able to bring their levels down 0.9% after 3 months, according to chart review data from 3 European countries.

Horizon and Aetion Partner to Optimize Treatment Pathways and Cut Healthcare Costs

June 7th 2019, 8:47pm


Aetion announced the company partnered with Horizon Healthcare Services to identify high-risk patients and optimal treatment pathways as a means to achieve better health outcomes and cut healthcare costs.

Data Show New US Diabetes Cases Are Taking a Dip

June 3rd 2019, 8:55pm


The authors, from the CDC, say that while the decline in diabetes incidence occurred alongside public health efforts, it's too soon to assume a causal relationship.